BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04866017-completion@plaintrial.com
DTSTAMP:20261027T135723Z
DTSTART;VALUE=DATE:20231017
SUMMARY:A Study to Compare Ociperlimab Plus Tislelizumab Versus Durvalumab 
 Following Concurrent Chemoradiotherapy (cCRT) in Participants With Stage I
 II Unresectable Non-Small Cell Lung Cancer — estimated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT04866017
URL:https://plaintrial.com/trial/NCT04866017
END:VEVENT
END:VCALENDAR